Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 5 studies | 22% ± 6% | |
epithelial cell | 5 studies | 27% ± 6% | |
ciliated cell | 4 studies | 22% ± 4% | |
GABAergic neuron | 4 studies | 37% ± 11% | |
astrocyte | 4 studies | 29% ± 6% | |
glutamatergic neuron | 4 studies | 43% ± 14% | |
oligodendrocyte | 4 studies | 21% ± 4% | |
oligodendrocyte precursor cell | 3 studies | 25% ± 5% | |
goblet cell | 3 studies | 25% ± 12% | |
transit amplifying cell | 3 studies | 22% ± 7% | |
interneuron | 3 studies | 35% ± 16% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 38% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 3104.40 | 459 / 459 | 100% | 75.10 | 1118 / 1118 |
esophagus | 100% | 2831.48 | 1445 / 1445 | 100% | 51.03 | 183 / 183 |
intestine | 100% | 3017.50 | 966 / 966 | 100% | 43.01 | 527 / 527 |
lung | 100% | 3069.38 | 578 / 578 | 100% | 45.92 | 1155 / 1155 |
pancreas | 100% | 2788.09 | 328 / 328 | 100% | 41.91 | 178 / 178 |
prostate | 100% | 3339.49 | 245 / 245 | 100% | 66.66 | 502 / 502 |
brain | 100% | 2544.20 | 2640 / 2642 | 100% | 44.38 | 705 / 705 |
bladder | 100% | 2741.95 | 21 / 21 | 100% | 38.43 | 503 / 504 |
uterus | 100% | 2841.74 | 170 / 170 | 100% | 35.75 | 458 / 459 |
kidney | 100% | 3415.51 | 89 / 89 | 100% | 41.76 | 898 / 901 |
stomach | 100% | 2953.80 | 359 / 359 | 100% | 42.20 | 285 / 286 |
skin | 100% | 3742.99 | 1809 / 1809 | 99% | 45.29 | 469 / 472 |
liver | 100% | 3516.10 | 226 / 226 | 99% | 35.37 | 403 / 406 |
thymus | 100% | 3308.92 | 653 / 653 | 99% | 36.10 | 600 / 605 |
adrenal gland | 100% | 3797.23 | 258 / 258 | 99% | 37.78 | 228 / 230 |
ovary | 100% | 2673.54 | 180 / 180 | 98% | 29.49 | 423 / 430 |
adipose | 100% | 2907.52 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 28.22 | 29 / 29 |
spleen | 100% | 2952.58 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 38.84 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 27.74 | 1 / 1 |
blood vessel | 100% | 2431.03 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 1446.83 | 846 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 30.32 | 76 / 80 |
muscle | 95% | 910.71 | 762 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 91% | 2744.45 | 847 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_2000654 | Biological process | regulation of cellular response to testosterone stimulus |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0071577 | Biological process | zinc ion transmembrane transport |
GO_0070830 | Biological process | bicellular tight junction assembly |
GO_0006882 | Biological process | intracellular zinc ion homeostasis |
GO_1905562 | Biological process | regulation of vascular endothelial cell proliferation |
GO_0005802 | Cellular component | trans-Golgi network |
GO_0031966 | Cellular component | mitochondrial membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005739 | Cellular component | mitochondrion |
GO_0005634 | Cellular component | nucleus |
GO_0022883 | Molecular function | zinc efflux transmembrane transporter activity |
GO_0005385 | Molecular function | zinc ion transmembrane transporter activity |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
GO_0005497 | Molecular function | androgen binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SLC39A9 |
Protein name | Zinc transporter ZIP9 (ZIP-9) (Solute carrier family 39 member 9) (Zrt- and Irt-like protein 9) Zinc transporter ZIP9 (Solute carrier family 39 member 9) (Zrt- and Irt-like protein 9) (ZIP-9) |
Synonyms | UNQ714/PRO1377 ZIP9 hCG_2028986 |
Description | FUNCTION: Transports zinc ions across cell and organelle membranes into the cytoplasm and regulates intracellular zinc homeostasis . Participates in the zinc ions efflux out of the secretory compartments . Regulates intracellular zinc level, resulting in the enhancement of AKT1 and MAPK3/MAPK1 (Erk1/2) phosphorylation in response to the BCR activation . Also functions as a membrane androgen receptor that mediates, through a G protein, the non-classical androgen signaling pathway, characterized by the activation of MAPK3/MAPK1 (Erk1/2) and transcription factors CREB1 or ATF1 (By similarity). This pathway contributes to CLDN1 and CLDN5 expression and tight junction formation between adjacent Sertoli cells (By similarity). Mediates androgen-induced vascular endothelial cell proliferation through activation of an inhibitory G protein leading to the AKT1 and MAPK3/MAPK1 (Erk1/2) activation which in turn modulate inhibition (phosphorylation) of GSK3B and CCND1 transcription . Moreover, has dual functions as a membrane-bound androgen receptor and as an androgen-dependent zinc transporter both of which are mediated through an inhibitory G protein (Gi) that mediates both MAP kinase and zinc signaling leading to the androgen-dependent apoptotic process . . FUNCTION: Transports zinc ions across cell and organelle membranes into the cytoplasm and regulates intracellular zinc homeostasis. Participates in the zinc ions efflux out of the secretory compartments. Also functions as membrane androgen receptor that mediates, through a G protein, the non-classical androgen signaling pathway, characterized by the activation of MAPK3/MAPK1 (Erk1/2) and transcription factors CREB1 or ATF1. Moreover, has dual functions as membrane-bound androgen receptor and as an androgen-dependent zinc transporter both of which are mediated through an inhibitory G protein (Gi) that mediates both MAP kinase and zinc signaling leading to the androgen-dependent apoptotic process. . FUNCTION: Transports zinc ions across cell and organelle membranes into the cytoplasm and regulates intracellular zinc homeostasis. Participates in the zinc ions efflux out of the secretory compartments. Also functions as membrane androgen receptor that mediates, through a G protein, the non-classical androgen signaling pathway, characterized by the activation of MAPK3/MAPK1 (Erk1/2) and transcription factors CREB1 or ATF1. Moreover, has dual functions as membrane-bound androgen receptor and as an androgen-dependent zinc transporter both of which are mediated through an inhibitory G protein (Gi) that mediates both MAP kinase and zinc signaling leading to the androgen-dependent apoptotic process. . FUNCTION: Transports zinc ions across cell and organelle membranes into the cytoplasm and regulates intracellular zinc homeostasis. Participates in the zinc ions efflux out of the secretory compartments. Also functions as membrane androgen receptor that mediates, through a G protein, the non-classical androgen signaling pathway, characterized by the activation of MAPK3/MAPK1 (Erk1/2) and transcription factors CREB1 or ATF1. Moreover, has dual functions as membrane-bound androgen receptor and as an androgen-dependent zinc transporter both of which are mediated through an inhibitory G protein (Gi) that mediates both MAP kinase and zinc signaling leading to the androgen-dependent apoptotic process. . |
Accessions | ENST00000628474.2 M0QX28 ENST00000556605.5 [Q9NUM3-3] ENST00000557046.1 [Q9NUM3-2] Q9NUM3 A0A0D9SFA2 ENST00000336643.10 [Q9NUM3-1] C4N9M8 ENST00000031146.8 ENST00000555840.5 [Q9NUM3-1] |